Tag: Health Care

Displaying 621 - 640 of 796 results.

The staff of the Federal Trade Commission recently told the Alaska House of Representatives' Committee on Labor and Commerce that legislation authorizing collective bargaining among the state's physicians would significantly increase health care costs in the state and harm its consumers....
The Federal Trade Commission today announced a consent agreement with American Home Products Corporation (AHP) that would settle charges that the company entered into an anticompetitive agreement with Schering-Plough Corporation (Schering) to delay entry of a lower-cost generic drug into the U.S....
A bill introduced in the Washington state legislature that seeks to authorize competing physicians, and other providers, to engage in collective bargaining with health plans over a variety of contract terms and conditions, including fees, would significantly increase health care costs and harm...
A bill pending before the Alaska legislature that seeks to authorize competing physicians to engage in collective bargaining with health plans over fees and other terms would significantly increase health care costs and harm consumers, according to the staff of the Federal Trade Commission. The...
The FTC has approved the issuance of two briefs, both of which are available on the Commission's Web site. The briefs were filed with respect to litigation involving: 1) Bristol-Myers-Squibb and Buspirone; and 2) The Hearst Trust and First Data Bank. A basic description of each brief is provided...
Amicus brief for the Federal Trade Commission, supporting argument of generic drug manufacturer that allegedly wrongful listing of patents in the FDA's "Orange Book" is not immune from antitrust liability.
Federal Trade Commission memorandum as amicus curiae (in the alternative to motion to intervene) to oppose grant of fees to private class action counsel, where much of the consumer recovery at issue resulted from the Commission's disgorgement action.
Staff of the Federal Trade Commission have advised the Connecticut Hospital Association (CHA) that the Non-Profit Institutions Act covers pharmaceuticals that its member hospitals dispense to their retired employees as permitted by state law.
The Federal Trade Commission today announced a proposed settlement with Hearst Corporation (Hearst) that would resolve charges that Hearst unlawfully acquired J.B. Laughery, Inc., which included the Medi-Span integratable drug information database business. Under the terms of the settlement,...
The staff of the Federal Trade Commission has negotiated an agreement with The Hearst Corporation (Hearst), which staff will propose to the Commission as a way to settle a permanent injunction action filed by the FTC. According to the Commission's April 5, 2001 complaint, Hearst failed to provide...
The Federal Trade Commission is the federal government's principal consumer protection agency, with broad jurisdiction extending over nearly the entire economy, including business and consumer transactions on the telephone, the Internet, and elsewhere.(1) Under the Federal Trade...
Consent agreement given final approval:
The Commission negotiated an agreement with The Hearst Corporation (Hearst) to settle a permanent injunction action filed by the FTC alleging that Hearst failed to provide documents required by premerger notification law and then consummated a merger that monopolized the integrated...
The Federal Trade Commission today charged The Hearst Trust, a family-held trust based in New York, New York; communications and entertainment company The Hearst Corporation, also in New York, which The Hearst Trust owns; and First DataBank, a wholly-owned Hearst Corp. subsidiary based in San...
In the complaint dated March 30, 2001 the Commission alleged that Schering - Plough, the manufacturer of K-Dur 20 - a prescribed potassium chloride, used to treat patients with low blood potassium levels - entered into anticompetitive agreements with Upsher-Smith Laboratories and...
The Federal Trade Commission today charged three drug makers, Schering-Plough Corporation ("Schering"), Upsher-Smith Laboratories ("Upsher-Smith") and American Home Products Corporation, with entering into anticompetitive agreements aimed at keeping low-cost generic drugs off the market.
The Federal Trade Commission today announced a consent agreement with Hoechst Marion Roussel ("HMR," now Aventis Pharmaceuticals, Inc), Carderm Capital, L.P. ("Carderm") and Andrx Corporation ("Andrx") to resolve an allegedly illegal agreement between the companies, affecting the $750 million a...
The Federal Trade Commission has announced its decision not to seek further review in the Supreme Court of its case against the California Dental Association ("CDA"), and has returned the matter to adjudication and dismissed the complaint. The Commission vote was 5-0. Chairman Robert Pitofsky and...
Under terms of a final consent order settling charges stemming from the merger of SmithKline and Glaxo Wellcome plc, the parties agreed to divest pharmaceutical products in six markets: antiemetics; the antibiotic, ceftazidime; oral and intravenous antiviral drugs for the treatment...

Pages